Feldmann Jérôme, Callebaut Isabelle, Raposo Graça, Certain Stéphanie, Bacq Delphine, Dumont Cécile, Lambert Nathalie, Ouachée-Chardin Marie, Chedeville Gaëlle, Tamary Hannah, Minard-Colin Véronique, Vilmer Etienne, Blanche Stéphane, Le Deist Françoise, Fischer Alain, de Saint Basile Geneviève
INSERM U429, Hôpital Necker-Enfants Malades, 75743 Paris, France.
Cell. 2003 Nov 14;115(4):461-73. doi: 10.1016/s0092-8674(03)00855-9.
Secretion of cytolytic granules content at the immunological synapse is a highly regulated process essential for lymphocyte cytotoxicity. This process requires the rapid transfer of perforin containing lytic granules to the target cell interface, followed by their docking and fusion with the plasma membrane. Defective cytotoxicity characterizes a genetically heterogeneous condition named familial hemophagocytic lymphohistiocytosis (FHL), which can be associated with perforin deficiency. The locus of a perforin (+) FHL subtype (FHL3), observed in 10 patients, was mapped to 17q25. This region contains hMunc13-4, a member of the Munc13 family of proteins involved in vesicle priming function. HMunc13-4 mutations were shown to cause FHL3. HMunc13-4 deficiency results in defective cytolytic granule exocytosis, despite polarization of the secretory granules and docking with the plasma membrane. Expressed tagged hMunc13-4 localizes with cytotoxic granules at the immunological synapse. HMunc13-4 is therefore essential for the priming step of cytolytic granules secretion preceding vesicle membrane fusion.
免疫突触处细胞溶解颗粒内容物的分泌是淋巴细胞细胞毒性所必需的高度调控过程。该过程需要将含有穿孔素的溶解颗粒快速转移至靶细胞界面,随后使其对接并与质膜融合。细胞毒性缺陷是一种名为家族性噬血细胞性淋巴组织细胞增生症(FHL)的遗传异质性疾病的特征,其可能与穿孔素缺乏有关。在10例患者中观察到的一种穿孔素阳性FHL亚型(FHL3)的基因座被定位到17q25。该区域包含hMunc13-4,它是参与囊泡启动功能的Munc13蛋白家族的成员。已证明HMunc13-4突变会导致FHL3。尽管分泌颗粒发生极化并与质膜对接,但HMunc13-4缺乏会导致细胞溶解颗粒胞吐作用缺陷。表达的标记化hMunc13-4定位于免疫突触处的细胞毒性颗粒。因此,HMunc13-4对于囊泡膜融合之前细胞溶解颗粒分泌的启动步骤至关重要。